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Speciﬁc language impairment (SLI) is a common developmental disorder characterized by difﬁculties in language acquisition despite
otherwise normal development and in the absence of any obvious explanatory factors. We performed a high-density screen of SLI1,
a region of chromosome 16q that shows highly signiﬁcant and consistent linkage to nonword repetition, a measure of phonological
short-term memory that is commonly impaired in SLI. Using two independent language-impaired samples, one family-based (211 fami-
lies) and another selected from a population cohort on the basis of extreme language measures (490 cases), we detected association to
two genes in the SLI1 region: that encoding c-maf-inducing protein (CMIP, minP ¼ 5.5 3 10
 7 at rs6564903) and that encoding calcium-
transporting ATPase, type2C, member2 (ATP2C2, minP ¼ 2.0 3 10
 5 at rs11860694). Regression modeling indicated that each of these
loci exerts an independent effect upon nonword repetition ability. Despite the consistent ﬁndings in language-impaired samples, inves-
tigation in a large unselected cohort (n ¼ 3612) did not detect association. We therefore propose that variants in CMIP and ATP2C2 act to
modulate phonological short-term memory primarily in the context of language impairment. As such, this investigation supports the
hypothesis that some causes of languageimpairment are distinct from factors that inﬂuencenormal languagevariation. This work there-
fore implicates CMIP and ATP2C2 in the etiology of SLI and provides molecular evidence for the importance of phonological short-term
memory in language acquisition.
Developmentalspeechandlanguagedisordersareahetero-
geneous group of childhood conditions with variable
presentation and etiology. Together, they account for 40%
of pediatric referrals
1 and statements of educational
need.
2 The term speciﬁc language impairment (SLI) deﬁnes a
category of speech and language disorders in which a
profound language impairment represents the primary
deﬁcit.
2Thisdisorderaffects5%–8%ofpreschoolchildren
2
and is highly heritable.
3 Nonetheless, in contrast to other
related developmental disabilities (e.g., dyslexia [MIM
#127700] and attention deﬁcit hyperactivity disorder
[ADHD, MIM #143465]), relatively few genetic studies
have been performed for SLI. SLI is a prototypical multifac-
torialdisorderthatispredictedtoinvolvenumerousgenetic
loci and environmental factors.
3 Three primary sites of
linkage have been described
4,5, the most robust of which
is on chromosome 16q (SLI1, MIM #606711). This region
isofinterestbecausethelinkageishighlyspeciﬁctoasingle
psychometric measure (nonword repetition).
4,6,7 The test
for nonword repetition involves the repetition of nonsen-
sical words of increasing length and complexity and is
regarded as a measure of phonological (speech sound) pro-
cessing and short-term memory.
8 Individuals with SLI typi-
cally perform particularly poorly on nonword repetition,
even when their language difﬁculties have apparently
resolved, leading to the postulation that a short-term
memory deﬁcit causes susceptibility to SLI
9 by impairing
the retention of novel verbal information.
10 This paper
incorporates two contingent investigations: an association
screen of the SLI1 region in a cohort of language-impaired
families and a subsequent replication study of detected
association effects in an independent sample selected
from the Avon Longitudinal Study of Parents and Children
(ALSPAC) general-population cohort.
11,12
The association screen utilized 806 individuals from 211
families ascertained by the SLI Consortium (SLIC). This
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across the UK (The Newcomen Centre at Guy’s Hospital,
London; the Cambridge Language and Speech Project
(CLASP)
13; the Child Life and Health Department at the
University of Edinburgh
14; the Department of Child
Health at the University of Aberdeen; and the Manchester
Language Study
15,16) and included the families in whom
the SLI1 linkage was originally identiﬁed. Ethical permis-
sion for each collection was granted by local ethics
committees. SLIC families were all selected on the basis
of a single proband with receptive and/or expressive
language skills more than 1.5 SD below the normative
mean for his or her age. A more detailed description of
these samples and the exclusionary criteria applied to the
SLIC collection can be found in previous publications.
4,6,7
Genotyping for the association screen was performed in
two phases with a combination of Sequenom and Illumina
technologies. We performed an initial high-density screen
involving 1906 SNPs to tag all 58 genes (including introns,
exons, and 5 Kb 50 and 2 Kb 30 of coding sequences) map-
ped to the 10.29 Mb SLI1 region of linkage (D16S3138–
D16S413. Chromosome 16 position 76.16 Mb–86.45 Mb
[B35]). Haplotype blocks were built within Haploview
17
via the Gabriel method.
18 Any between-block gap that
was more than 15 Kb in size was tagged with the Tagger
algorithm. Two genes that mapped to the region (CDH13
[MIM #601364] and WWOX [MIM #605131]) were found
to be larger than 1 Mb in size. For these two genes, blocks
were built to cover the exonic regions only. Any region
containing a SNP that met our predeﬁned signiﬁcance
threshold (p < 0.001 in any one analysis or p < 0.01 across
both analyses) was then supplemented with additional
markers in a follow-up panel that included 138 SNPs, eight
of which had previously been genotyped. Both phases of
genotyping were completed prior to the replication study
and were subjected to consistent quality-control proce-
dures. The total genotype mismatch rate was 0.73% for
duplicated SNPs and 0.76% for duplicated samples. Across
both phases, 261 (12.7%) of SNPs were excluded at the
quality-control stage.TheseincludedSNPs withagenotype
rate of <80%, a minor-allele frequency of <2.5%, SNPs
with unusual Beadstudio cluster patterns (Illumina) or
atypical peaks in MassArray TyperAnalyser (Sequenom),
SNPs with a GenTrain score of <0.5 (Illumina), and
markers that showed consistent bad inheritances (>10
errors after data clean up). Across the entire region, the
merged data set consisted of, on average, one SNP every
6.4 Kb. Across the known genes, there was on average
one SNP every 4.5 Kb, and the largest remaining gap
between blocks was 19,579 bp. Details of SNP coverage
can be found in Table S1. Q-Q plots can be found in
Figure S1. Given the consistent linkage between SLI1 and
nonword repetition, all association analyses were based
upon this measure. Our principal analysis involved the
variance-components modeling of 28-item nonword repe-
tition scores
8 within 211 SLIC families (ao option) as
a quantitative trait and was performed within QTDT.
19 In
addition, we performed a categorical case-control allelic
test of association within PLINK.
20 In this case-control
analysis, SLIC individuals with low nonword-repetition
scores (>2 SD below population mean, n ¼ 79) were
chosen as cases, and family members with above-average
performance (>0.5 SD above population mean, n ¼ 71)
were used as controls. To avoid interdependence, we
selected only one case or control from each family unit.
The initial screen involved 1678 SNPs, of which thirteen
(0.77%) exceeded our signiﬁcance threshold, highlighting
two primary regions of association (Table 1 and Figure 1).
The follow-up panel chieﬂy included SNPs in these two
regions and supported the association seen in the screen
while reducing the evidence for association at other loci
(Table 2 and Figure 1). Of the 105 SNPs tested in the
follow-up panel, ﬁve (4.8%) were found to be signiﬁcantly
associated (Table 2 and Figure 1). The ﬁrst identiﬁed cluster
of association lay across 26 Kb (exons 2–4) of the CMIP
gene (MIM #610112; seven signiﬁcant SNPs, minP ¼ 5 3
10
 7). This gene encodes an adaptor protein and has two
isoforms, the shorter of which is involved in cell signaling
pathways and is upregulated in minimal change nephrotic
syndrome (MCNS), a childhood kidney disease.
21 Little is
known about the function of the longer transcript. Both
isoforms are expressed in the brain.
21 The second region
of association was observed between exons 7 and 12
(10.8 Kb) of the ATP2C2 gene (six signiﬁcant SNPs, minP ¼
2 3 10
 5). This gene is one of two secretory-pathway Ca
2þ-
ATPases (SPCAs) that move cytosolic calcium and manga-
nese ions into the golgi.
22 Its expression is limited to the
brain, testis, gastrointestinal tract, and respiratory tissues
and mammary, salivary, and thyroid glands.
22 In the
mammary gland, ATP2C2 expression facilitates the secre-
tion of Ca
2þ into casein micelles during lactation.
23
Three lines of evidence indicate that the associations at
CMIP and ATP2C2 represent separate effects. First, we did
notseeanyindicationoflong-rangelinkagedisequilibrium
between the two loci (which lie almost 3 Mb apart) in the
SLICcohortorpublicdata(FigureS2).Second,theinclusion
of a CMIP covariate in the linkage or association model did
not affect the level of linkage orassociation seen at ATP2C2
(or vice versa for ATP2C2 covariates) (Figure S3). Finally, in
a stepwise regression model, the group mean for SLIC indi-
viduals carrying a double-risk genotype was found to be
signiﬁcantly lower than those who were homozygous for
riskatasinglelocus(p¼3.7310
 6,Table3).Inthismodel,
the group mean for double-risk individuals was 15.8 points
(1.05 SD) below that of individuals carrying nonrisk vari-
ants at both loci (Table 3). We therefore propose that
CMIP andATP2C2 independently regulate nonword repeti-
tion performance and together underlie the linkage seen
between SLI and chromosome 16.
Our replication sample consisted of 490 cases selected
from the Avon Longitudinal Study of Parents and Children
(ALSPAC) cohort.
11,12 This is a general-population sample
that follows the development of 14,062 live-born individ-
uals born in the southwest of England. The ALSPAC group
The American Journal of Human Genetics 85, 264–272, August 14, 2009 265Table 1. Signiﬁcant Association in the SLIC Association Screen
SNP
Chromosome
Position
(bp – B36) Gene
Alleles
(A1/A2)
A1 CEPH
Frequency
Typed
Strand p Quant
Effect
Size Heritability
p Emp
QTDT p Case-Cont
Frequency
of A1 Cases
Frequency
of A1 Controls
Odds ratio
(95% CI)
p Emp
PLINK
rs8051754 78,554,834 intergenic T/C* 0.46   0.0931  0.28 5 0.11 0.019 0.0892 0.0007* 0.64 0.85 3.1 (1.6–6.0) 0.0018*
rs4417561 78,568,860 intergenic G*/C 0.26   0.0244  0.30 5 0.11 0.022 0.0252 0.0004* 0.37 0.15 3.2 (1.7–6.3) 0.0011*
rs2316184 79,204,885 CDYL2 G/A* 0.14 þ 0.0032* -0.48 5 0.12* 0.045 0.0034* 0.0096* 0.15 0.30 2.5 (1.2–4.9) 0.0126
rs12927866 80,209,823 CMIP A/G* 0.47   0.4104  0.27 5 0.10 0.019 0.3581 0.0003* 0.29 0.49 2.4 (1.5–3.9) 0.0004*
rs4265801 80,222,553 CMIP T*/G 0.43 þ 0.3446  0.09 5 0.09 0.030 0.5065 4 3 10
 5* 0.61 0.29 3.9 (2.0–7.6) 0.0393*
rs7201632 80,234,949 CMIP C/T* 0.49 þ 0.8966  0.25 5 0.09 0.017 0.7975 0.0004* 0.36 0.56 2.3 (1.4–3.7) 0.0004*
rs3785054 82,918,978 WFDC1 C*/T 0.36   0.0044*  0.29 5 0.10* 0.019 0.0033* 0.0089* 0.34 0.20 2.0 (1.2–3.4) 0.0102
rs8053211 83,011,254 ATP2C2 A*/G 0.46 þ 5 3 10
 5*  0.38 5 0.09* 0.040 3 3 10
 5* 0.0014* 0.61 0.43 2.1 (1.3–3.3) 0.0029*
rs11860694 83,014,948 ATP2C2 C*/G 0.54   2 3 10
 5*  0.37 5 0.09* 0.039 9 3 10
 6* 0.0018* 0.61 0.43 2.1 (1.3–3.3) 0.0027*
rs16973771 83,018,079 ATP2C2 G/A* 0.48   0.0003*  0.35 5 0.09* 0.034 0.0006* 0.0025* 0.34 0.51 2.0 (1.3–3.2) 0.0036*
rs2875891 83,021,410 ATP2C2 T/C* 0.44 þ 0.0057*  0.34* 5 0.10* 0.031 0.0063* 0.0022* 0.30 0.47 2.1 (1.3–3.4) 0.0026*
rs8045507 83,022,078 ATP2C2 T/C* 0.48   0.0017*  0.33 5 0.09* 0.029 0.0020* 0.0022* 0.34 0.51 2.1 (1.3–3.3) 0.0028*
Three signiﬁcant SNPs fell within the CMIP gene, and ﬁve fell within ATP2C2. The remaining four signiﬁcant SNPs were either intergenic or isolated signals of association. SNP alleles are given with the minor allele in the SLIC
sample ﬁrst. Putative risk alleles are marked with an asterisk. P Quant gives the p value for the quantitative, family-based analysis. p case-cont gives the p value for the case-control analysis. p values <0.01 are marked with an
asterisk. The odds ratios indicate the ratio of case/control odds for each additional copy of the putative risk allele. Odds ratios were calculated within PLINK. The effect size is the estimated effect of each risk allele on the
nonword repetition score (in SD 5 SE). Effect sizes were calculated with MERLIN. Heritability gives the proportion of total variance explained by the SNP. Heritability estimates were calculated with MERLIN. The p Emp
column gives empirical p values for the given SNP; these values were derived from permutations within QTDT or PLINK.
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9periodically performs an assessment of the development of
consenting individuals, and these measurements include
tests of language ability. Informed written consent was ob-
tained from the parents at the time of enrolment. Ethical
approval for the study was obtained from the ALSPAC
Law and Ethics Committee and the Local Research Ethics
Committees. Because the current study focuses upon
language impairment, we selected individuals from the
lower extreme of language-related phenotype distributions
(Children’s Communication Checklist (CCC)
24 and
Wechsler Objective Language Dimensions (WOLD)
25) for
our replication sample. This included 665 individuals
(10.3%) with a CCC pragmatic composite 1–3 SD below
the ALSPAC population mean (123 % 3 % 145) or a
WOLD listening comprehension score R2 SD below the
ALSPAC population mean (%3). Of these individuals,
490 had completed a 12-item nonword repetition test.
Because the genotyping in the replication sample was
restricted to a single individual from each family, we per-
formed a quantitative association analysis within PLINK
20
by using nonword repetition in a linear-regression frame-
work. In addition, we used PLINK
20 to carry out a case-
control analysis analogous to that described for SLIC. We
selected cases and controls from the extremes of the
nonword repetition performance distribution of the 490
selected individuals. As expected, given the extreme nature
of the language impairment in the SLIC samples, the distri-
bution of nonword repetition differed between the SLIC
and ALSPAC cohorts. Therefore, in the replication cohort,
the cut-offs used for cases and controls were less extreme
than those applied for the association screen. Cases were
selected from the identiﬁed replication sample to have
nonword repetition scores R1 SD below the general-popu-
lation mean (n ¼ 112), and controls had nonword repeti-
tion scores R1 SD above the general-population mean
(n ¼ 72). Data were analyzed for three CMIP and three
ATP2C2 SNPs (rs12927866, rs4265801, and rs16955705;
and rs16973771, rs2875891, and rs8045507, respectively),
and signiﬁcant associations (p < 0.05) were seen for two
CMIP and two ATP2C2 SNPs (Table 4 and Figure 2). Regres-
sion trends for ATP2C2 followed those seen in SLIC, repli-
cating the previously described association. Association to
CMIP was in an opposite direction from that described
above (Table 4 and Figure 2). Although this result might
represent a type I error, the consistency of signiﬁcant asso-
ciation in light of the low number of SNPs tested supports
a role for CMIP. Associations can occur in opposite direc-
tions if the relationship between the observed and causal
variants differs between populations.
26 This is particularly
true if multiple risk loci interact in an additive or multipli-
cative fashion
26, as is predicted for CMIP. Identiﬁcation of
the causal variant will enable the further characterization
of the relationship between risk variants in different popu-
lations.
Given the partial replication of association, we investi-
gated whether the primary associated SNPs in ATP2C2
and CMIP had an effect upon additional language- and
memory-related measures (Table S2). In SLIC, we found
borderline association for ATP2C2 with measures of recep-
tive language (oral directions
27 [p ¼ 0.006], word classes
27
[p ¼ 0.04], and comprehension
28 [p ¼ 0.03]), expressive
language (formulating sentences
27 [p ¼ 0.04]), and vocab-
ulary
28 (p ¼ 0.04). In the replication cohort, aside from
nonword repetition, we only observed borderline associa-
tion between ATP2C2 and counting span, a measure of
working memory (p ¼ 0.01). In the replication sample,
nonword repetition performance had been scored accord-
ing to the number of syllables the nonword contained.
For both CMIP and ATP2C2, the majority of association
came from the ﬁve-syllable nonwords (p ¼ 0.016 and p ¼
6 3 10
 4, respectively) (Table S2). In neither sample did
we observe association to reading-related tasks, which
have been reported to show linkage to SLI1.
6 Nor did we
ﬁnd any association to digit span
28 or recalling senten-
ces,
27 two measures that have a high memory load. This
is consistent with the ﬁnding that nonword repetition
correlates with SLI to a higher degree than other short-
term memory tests (e.g., digit span). The sensitivity of
Figure 1. Association in SLIC Cohort
Association results for family-based quantitaive analysis and case-control analysis of nonword repetition across the SLI1 region. In the
case-control analysis, cases and controls were selected on the basis of their nonword-repetition performance (see text). Gaps in data
represent regions where there are no mapped genes. SNPS included in the screen genotype panel are shown as þ, and SNPs included
in the follow-up genotype panel are shown as x.
The American Journal of Human Genetics 85, 264–272, August 14, 2009 267nonword repetition to SLI could be because it places
heavier demands on processing of speech sounds than
other memory tests as a result of the child’s having to
perceive and produce an unfamiliar sequence.
29 It is
important to note that, although nonword repetition is
a good marker for SLI, poor performance on nonword repe-
tition is not a perfect correlate of this disorder.
30 In our
study, 50% of SLIC probands performed poorly (>1S D
below the expected population mean) on nonword repeti-
tion, but a signiﬁcant number (27%) scored above the ex-
pected population mean. These ﬁndings support recent
opinion that deﬁcits across multiple domains are required
to cause persistent language impairments.
31
A recent genome-wide association study of ADHD listed
a SNP (rs10514604; p ¼ 8 3 10
 7)i nATP2C2 within the
top 30 signiﬁcant associations.
32 Despite distinct deﬁning
characteristics, ADHD and SLI show a high level of comor-
bidity both with each other
32 and with disorders such as
developmental coordination disorder, speech-sound
disorder (SSD; MIM #608445), and dyslexia.
33–35 For
example, individuals with SLI, SSD, ADHD, or dyslexia
often present with linguistic deﬁcits and impairments in
short-term memory.
33 It has therefore been suggested
that certain aspects of these disorders might share a
common etiology. Given the high levels of co-occurrence,
we did not exclude children affected by ADHD and
dyslexia from our study samples. However, in some of
our SLIC samples, data were available for the presence of
hyperactivity, coordination, and reading problems. From
this, we estimate that approximately one-third of our
SLIC samples showed some evidence of ADHD or develop-
mental coordination disorder and that approximately one-
half of our probands had reading problems. In the entire
ASLPAC sample, 1.3% of individuals met criteria for
ADHD. In the selected ALSPAC replication sample, the
rate of ADHD increased to 3.7%. Thus, as expected, it is
clear that the rate of developmental disorders across our
cohorts is elevated over that expected in a population
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Table 3. Nonword-Repetition Group Means for CMIP and ATP2C2
Risk Variants
Genotype
(Number of
Risk Alleles)
Single
SNP
rs6564903 (CMIP)
TT (0) CT (1) CC (2)
Single SNP 96.62 92.57 86.30
rs11860694 (ATP2C2) GG (0) 96.54 99.14 99.85 89.65
CG (1) 91.77 99.40 93.10 85.84
CC (2) 87.03 88.44 88.33 83.32
The effects of CMIP (rs6564903) and ATP2C2 (rs11860694) on nonword-repe-
tition performance were modeled as additive effects within a regression frame-
work in the R package. This regression model included all available SLIC chil-
dren with genotype and nonword-repetition data (n ¼ 503). Group means
were calculated for each SNP in isolation (‘‘Single SNP’’ entries) and in combi-
nations of genotypes (3 3 3 grid) across risk SNPs. Note that individuals
carrying combinations of risk alleles performed signiﬁcantly worse than those
carrying risk variants at a single locus. Nonword-repetition scores are age
adjusted and standardized against normal population controls with a mean
of 100 and a SD of 15.
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samples shows a strong correlation to nonword-repetition
ability which has repeatedly been shown to be a strong
indicator of language impairment.
9,10 Furthermore, in
ADHD samples, performance on the nonword-repetition
task is correlated with linguistic ability rather than the
presence of hyperactivity.
33,36 Thus, we conclude that vari-
ants in ATP2C2 might account for shared aspects of the
linguistic deﬁcit in SLI and ADHD. Given this possibility,
we also postulate that ATP2C2 might contribute to pho-
nological short-term memory in other developmental
disorders.
Finally, we investigated the effects of ATP2C2 and CMIP
on nonword-repetition performance at the population
level. Across the entire unselected ALSPAC population
(n ¼ 3612), there was no evidence for quantitative associ-
ation between nonword-repetition ability and either locus
(minP ¼ 0.48). Moreover, there were no differences in
allele frequency for ATP2C2 or CMIP SNPs between either
SLIC or replication-sample individuals and unselected
European population controls (data not shown). Taken
together, these data indicate that ATP2C2 and CMIP do
not modulate nonword-repetition performance across
the entire population, nor, in isolation, do they cause
Table 4. Association in the Replication Cohort
SNP
Chromosome
Position
(bp – B36) Gene
Alleles
(A1/A2)
SLIC Risk
Allele
A1 CEPH
Frequency
Typed
Strand
p
Quant
Effect
Size
p Case-
Cont
Frequency
of
A1 Cases
Frequency
of
A1 controls
Odds Ratio
(95% CI)
rs12927866 80,209,823 CMIP T/C C 0.47 þ 0.1623  0.08 0.0955 0.39 0.30 1.5 (0.9-2.3)
rs4265801 80,222,553 CMIP T/G* T 0.43 þ 0.0182*  0.15 0.0214* 0.43 0.56 1.6 (1.1-2.5)
rs16955705 80,230,851 CMIP C*/A A 0.50 þ 0.0238*  0.14 0.0257* 0.48 0.36 1.6 (1.1-2.5)
rs16973771 83,018,079 ATP2C2 C/T* T 0.48 þ 0.0079*  0.14 0.0135* 0.32 0.45 1.7 (1.1-2.7)
rs2875891 83,021,410 ATP2C2 T/C C 0.44 þ 0.0668  0.06 0.0802 0.29 0.37 1.5 (1.0-2.3)
rs8045507 83,022,078 ATP2C2 A/G* G 0.48 þ 0.0058*  0.15 0.0110* 0.31 0.44 1.8 (1.1-2.7)
SNP alleles are given with the minor allele ﬁrst. Putative risk alleles in the replication cohort are marked with an asterisk. p Quant shows the p value for the quan-
titative analysis. p < 0.05 are highlighted in bold. The odds ratio indicates the ratio of case/control odds for each additional copy of the putative risk allele. The 95%
conﬁdence intervals for the odds ratios of all signiﬁcantly associated SNPs exceeded 1.0. The effect size is the estimated effect of each risk allele on the nonword-
repetition score (in SD).
Figure 2. Nonword-Repetition Means
for CMIP and ATP2C2 in SLIC and Replica-
tion Cohorts
(A) CMIP.
(B) ATP2C2.
All means are for age- and sex-adjusted
nonword-repetition scores standardized
with a mean of 0 and a SD of 1. The three
CMIP SNPs (rs12927866, rs4265801, and
rs16955705) show genotype trends in the
opposite direction from SLIC (A), whereas
the three ATP2C2 SNPs (rs16973771,
rs2875891, and rs8045507) show geno-
type trends in the same direction as SLIC
(B).
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combined with additional, as-yet-unidentiﬁed, suscepti-
bility factors (either genetic or environmental), variants
in ATP2C2 and CMIP have a detrimental effect upon
nonword repetition performance and thus heighten the
risk of developmental language impairments. This situa-
tion demonstrates a fundamental principle often over-
looked in the mapping of complex disorders: that genetic
variants might have selective effects in speciﬁc popula-
tions depending upon the genetic and environmental
background. The question as to whether SLI constitutes
a qualitatively distinct disorder caused by abnormal devel-
opment of language abilities or merely represents the tail
end of normal linguistic development is a matter of recent
debate.
37 Although the absence of association in our pop-
ulation sample could reﬂect insufﬁcient sample sizes or the
insensitivity of psychometric tests to quantify variation
beyond the lower extremes of the spectrum, it is obvious
that the effects of ATP2C2 and CMIP upon nonword-repe-
tition performance are particularly pertinent to individuals
with language difﬁculties. As such, this investigation
provides molecular evidence that, at least in terms of the
effects described here, SLI represents a distinct disorder
caused by genetic variants discrete from those that inﬂu-
ence language ability in the general population.
In summary, we have used a positional ﬁne-mapping
approach to demonstrate association between ATP2C2
and CMIP and nonword repetition performance across
two independent language-impaired populations. We
propose that variants in both loci combine to modulate
nonword-repetition performance in language-impaired
populations. Both genes are expressed in the brain and
represent good candidates for language- and memory-
related processes. ATP2C2 is involved in the translocation
of cytosolic calcium and manganese ions to the golgi.
22
Calcium homeostasis is important for the regulation of
many neuronal processes, including working memory,
synaptic plasticity, and neuronal motility
38, and manga-
nese dysregulation has been linked to Parkinsonism
(MIM #168600), Alzheimer disease (MIM #104300), and
disordered memory.
39 The functional role of CMIP is less
deﬁned, but it is known to interact with ﬁlamin A (MIM
#300017)
40 and the NF-kappaB subunit RelA (MIM
#164014).
41 The ﬁlaminA protein is involved in the reorga-
nization of the actin cytoskeleton, which is of importance
in the formation of the dendritic spine.
40 The NF-kB family
of transcription factors plays a central role in many
neuronal processes, including synaptic activity and
memory formation, and members of this family have
been implicated in neurodegenerative disorders.
42 Further
characterization of the observed associations has enabled
us to infer that SLI represents a qualitatively distinct
disorder caused by a combination of genetic variants that
disrupt multiple pathways important to the development
of language. It is anticipated that the functional character-
ization of ATP2C2 and CMIP will promote a better under-
standing of the molecular basis of language acquisition
and aid in the diagnosis and treatment of individuals
affected by language disorders.
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